FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, specifically to production of T cells expressing a chimeric antigen receptor (CAR) that specifically binds to CD171; it can be used in medicine.
EFFECT: obtained cells can be used in the effective therapy of cancer expressing CD171.
30 cl, 21 dwg, 8 tbl, 1 ex
| Title |
Year |
Author |
Number |
| DRUG-REGULATED TRANSGENIC EXPRESSION |
2015 |
|
RU2751920C2 |
| TRANSGENIC GENETIC LABELS AND METHODS OF USE |
2015 |
- Dzhensen, Majkl K.
- Dzhonson, Adam
|
RU2822461C1 |
| TRANSGENIC GENETIC LABELS AND METHODS OF USING |
2015 |
- Dzhensen Majkl K.
- Dzhonson Adam
|
RU2729112C2 |
| METHOD AND COMPOSITIONS FOR CELL IMMUNOTHERAPY |
2013 |
- Jensen, Michael
- Riddell, Stanley, R.
- Hudecek, Michael
|
RU2700765C2 |
| PRODUCTS OF A CERTAIN COMPOSITION CONTAINING GENETICALLY MODIFIED T CELLS |
2015 |
|
RU2751921C2 |
| CHIMERIC RECEPTORS CONTAINING TRAF-6-INDUCING DOMAINS AND COMPOSITIONS AND METHODS RELATED TO THEM |
2016 |
- Thompson, Lucas, James
- Odegard, Valerie
- Sather, Blythe
- Brahmandam, Archana
|
RU2773159C2 |
| METHODS FOR PRODUCTION OF COMPOSITIONS OF GENETICALLY ENGINEERED CELLS AND RELATED COMPOSITIONS |
2018 |
- Mujacic, Mirna
- Rahardjo, Ayu
|
RU2790444C2 |
| METHODS AND COMPOSITIONS FOR OBTAINING GENETICALLY ENGINEERED CELLS |
2018 |
|
RU2795454C2 |
| COMBINATION THERAPY FOR THE TREATMENT OF BCMA-RELATED CANCER AND AUTOIMMUNE DISORDERS |
2018 |
- Riddell Stanley R.
- Green Damian
- Hill Tyler
|
RU2799762C2 |
| MULTI-CHAIN CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF |
2013 |
- Smit Dzhulianna
- Sharenberg Endryu
- Manniui Sesil
- Ekem Zhyusten
|
RU2663725C2 |
